Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Joanna
Contact Joanna, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
CD37 is a promising molecular target for CAR-T cells in chronic lymphocytic leukemia
Abstract Chronic lymphocytic leukemia (CLL) represents the most common form of adult B-cell malignancy. Although significant therapeutic progress has been made in the recent years, novel molecular targets are still being investigated, and the management of relapsed or refractory (r/r) CLL remains challenging. Chimeric antigen receptor (CAR)-T cell therapies have revolutionized treatment in other B-cell malignancies and are emerging as a feasible option for a subset of r/r CLL patients.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Joanna
Contact Joanna, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack